31.08.2023  21:59:59 Изменение - Объем сделки Бид1:50:00 Предложение1:50:00 Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
39.7500USD - 31.37 млн
Оборот: 336.35 млн
39.2900Величина цены спроса: - 39.9000Величина цены предложения: - 2.08 млрдUSD - 50.96

Описание деятельности

NuVasive is a global medical device company focused on transforming spine surgery by empowering surgeons with technology to approach procedures in the least disruptive way possible and restore the vitality of life for those that suffer from debilitating spinal conditions. Through its minimally invasive, procedurally-integrated solutions, the Company is expanding the boundaries of modern healthcare with technologies and surgeon training designed to provide reproducible and clinically-proven surgical outcomes that are redefining the success factors of spine surgery like never before. Addressing a variety of pathologies up and down the spine, from complex spinal deformity to degenerative spinal conditions, NuVasive's highly differentiated solutions include access instruments, implantable hardware and increasingly expert software systems like its game-changing iGA™ surgical planning and reconciliation technology that centers on achieving the global alignment of the spine. NuVasive believes its integrated approach and expertise can fundamentally evolve spine care by delivering improved patient experiences, and better economics for healthcare systems.
 

Правление & Наблюдательный совет

Исполнительный директор
J. Christopher Barry
Правление
Matthew K. Harbaugh, Aviva McPherron, Brent Boucher, Dale Wolf, Kyle Malone, Lucas Vitale, Massimo Calafiore, Michael Farrington, Nathaniel Sisitsky, Sean Freeman
Наблюдательный совет
Daniel J. Wolterman, Amy Belt Raimundo, Donald J. Rosenberg, J. Christopher Barry, John A. DeFord, Leslie V. Norwalk, R. Scott Huennekens, Robert F. Friel, Siddhartha Kadia, Vickie L. Capps
 

Данные компании

Имя: NuVasive Inc.
Адрес: 7475 Lusk Boulevard,San Diego, California 92121, USA
Телефон: +1-858-909-1800
Факс: +1-800-475-9134
E-mail: info@nuvasive.com
Интернет: www.nuvasive.com/
Индустрия: Healthcare
Сектор: Medical Products
Подсектор: Advanced Medical Devices
Конец финансового года: 31.12
Акции в свободном обращении: 60.20%
Дата IPO: -

Связи с инвесторами

Имя: Juliet C. Cunningham
IR телефон: +1-858-458-2240
IR-факс: -
IR e-mail: investorrelations@nuvasive.com

Основные акционеры

Freefloat
 
60.20%
Wellington Management Company LLP
 
13.00%
BlackRock, Inc.
 
12.20%
The Vanguard Group
 
9.40%
The Hartford Mutual Funds, Inc.
 
5.20%